__

RockBrook Gears Up to Commercialize the Cannabis Science Brand of Pharmaceutical Products as Another Medical Cannabis Dispensary Breaks More Industry Ground as It Airs One of the First Paid TV Ads on FOX Affiliate KTXL in Sacramento, California

Cannabis Science, Inc. (OTCBB: CBIS), a pioneering U.S. biotech company developing pharmaceutical cannabis products, is pleased with its progress with RockBrook Inc. as its first commercialization license for the Cannabis Science Brand of Pharmaceutical Products for the State of Colorado.

The licensing agreement grants RockBrook the full latitude and rights to manufacture, develop, produce, distribute, and sell products developed from, or based on Cannabis Science formulations, and delivery systems for the Cannabis Science Brand of Pharmaceutical Products and Cannabis Science Ailment Formulations within the State of Colorado.

On August 30, 2010, FOX affiliate KTXL (”FOX40″) aired one of the first paid U.S. television ads for a Cannabis Dispensary called CannaCare on its FOX40 Live morning news program. The 30-second ad focused on cannabis relief (treatment) for various medical ailments using true-life patient testimonials.

Similarly, Cannabis Science is acquiring public testimonials using data acquired from RockBrook patients who use Cannabis Science Brands to evaluate our medical marijuana products prior to FDA clinical trials.

Cannabis Science - The Real Deal

Cannabis Science, Inc. (OTCBB:CBIS) , a pioneering U.S. biotech company developing pharmaceutical cannabis products, has issued a statement regarding a Canadian study on marijuana and intractable post-traumatic or post-surgery neuropathic pain that did not respond to conventional treatment. In this multi-billion dollar market, this is very encouraging news for Cannabis Science shareholders as even small doses of cannabis provided relief from chronic, neuropathic pain, which may be caused by physical injuries or by anti-viral drugs used to treat HIV/AIDS. Neuropathic pain is also common in cancer patients as a direct result of the cancer, or as a side effect of chemotherapy, radiation or surgery.

Cannabis Science President and CEO Dr. Robert Melamede, PhD., commented, “Obviously, this study gives further support to our plans to work within the multi-billion dollar market of chronic neuropathic pain. As Dr. Ware said at the beginning of the CMAJ article, cannabis sativa has been used to treat pain since the third millennium BC, so it is all the more outrageous that it has taken so long for such a study to be done, and it could only be used by patients who did not respond to anything else. Why do they have to suffer so much to prove what almost all medical marijuana users already know?”

McGill’s study is the first double-blind, placebo-controlled trial conducted with outpatients who were allowed to smoke marijuana in their own homes. Participants were divided into four groups and randomly assigned marijuana containing four levels of tetrahydrocannabinol (THC), the active ingredient: at 9.4 per cent, 6.0 per cent, 2.5 per cent, and zero THC. The study was led by anesthesiologist Mark Ware, director of clinical research at Montreal’s Alan Edwards Pain Management Unit at the McGill University Health Centre. It was published in the Canadian Medical Association Journal.

Richard Cowan, Cannabis Science CFO, added, “This study demonstrates the importance of our licensing agreement with the RockBrook dispensary of Denver which we announced on August 18th, which gives us the immediate ability to test our formulations with humans to help determine exactly what doses and strains work best for patients as we prepare to enter clinical trials.”

About Cannabis Science, Inc.

Cannabis Science, Inc. is at the forefront of medical marijuana research and development. Cannabis Science works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce, and commercialize phytocannabinoid-based pharmaceutical products. In sum, Cannabis Science is dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.

http://www.cannabisscience.com

__

WindPower Innovations, Inc. (PINK SHEETS:WPNV), a wind power infrastructure and smart grid solutions company, reported yesterday the availability of a recent interview with Chief Technical Officer Ian K. Griffiths conducted by Virmmac.com, a virtual IR, marketing, media, and administration center focused on providing companies ongoing support, and Stocktalk101.com, designed to educate traders and investors alike in OTC and Pink sheet companies, will air the interview via a pod cast, on Tuesday, September 7th, 2010 at 09:00 am EDT. The interview will be available on Virmmac’s and Stocktalk101’s (www.stocktalk101.com) homepage. Mr. Griffiths will discuss in detail the unique nature of WindPower Innovations, Inc. and how it sees its role in the evolution of wind energy.

Furthermore, WindPower Innovations also reports talks with Energy Plus, an Alternative Energy Company, regarding distribution of WindPower Innovation’s Permanent Magnet Generator and Grid-Tie Technology throughout Mexico and Central America. Energy Plus distributes alternative energy solutions throughout Mexico and Latin America, and the invitation to expand its palette of offerings, helping to address the requirements of its long standing relationships, represents a strategic marketing opportunity for WindPower Innovations and Energy Plus.

“Many potential markets for wind energy are un-tapped because the technology most widely available requires constant wind speeds at only one to two optimum peaks (+/-5%),” says Ian Griffiths, Chief Technical Officer of WindPower Innovations. “Since it’s a smart technology that can sense variable load demands and adjust power output accordingly, our Permanent Magnet and custom Grid-Tie solutions are ideal for regions that have inconsistent wind supply or power grid challenges, meeting the varying power needs from country to country, small villages, extreme climates and/or areas with developing infrastructure. Constant power can be generated consistently over a very wide band of operation (from 20% TO 125% of rated power).”

WindPower Innovations, Inc., is a wind power infrastructure and smart grid solutions company that is continually working on new innovations for wind turbines, wind energy generation and transmission, in addition to the comprehensive maintenance, repair and re-manufacture of exiting equipment.

http://www.windpowerinnovationsinc.com

__

US Airways Realigns Leadership Team to Strengthen Operational Momentum

Building on its industry-leading operational performance, US Airways (NYSE: LCC) today announced a realignment of its operations leadership team to strengthen its planning, analysis and technology expertise. The three executive promotions were approved by the Company’s Board of Directors.

Kerry Hester, 40, previously vice president, reservations and customer service planning has been promoted to senior vice president, operations planning and support. In her new role, Hester will take on responsibility for operations planning and analysis and share oversight of the crew resources function, while continuing to maintain oversight of reservations and the strategy, planning and service recovery functions within customer service. She will continue to report to US Airways Chief Operating Officer Robert Isom.

Tim Lindemann, 44, formerly managing director, customer strategy and planning has been promoted to vice president, reservations and customer planning. Lindemann will assume responsibility for the reservations organization, including the reservations planning and network operations functions, as well as the policies and procedures and training functions for both the call centers and airports. He will continue to report to Hester.

Bob Maloney, 57, formerly managing director, operations control center (OCC), has been promoted to vice president, operations control center and air traffic control. He will continue to oversee the airline’s Pittsburgh-based OCC which manages system-wide day-to-day departure, in-flight and arrival logistics. Maloney, a 36-year airline industry veteran, will also gain responsibility for the airline’s air traffic control and airfield operations groups. Maloney will report to Captain Ed Bular, senior vice president, flight operations and inflight.

“Over the past three years, the US Airways team has achieved a remarkable operational turnaround, and we’ve emerged a consistent leader in operational reliability. As we return our airline to sustained profitability and position US Airways for the opportunities ahead, it is critical that we continue to build on our operational strengths by bolstering our planning, analysis and technical expertise. Kerry, Tim and Bob have made significant contributions to our airline, and we are confident that with today’s realignment, their leadership and expertise will help drive additional efficiencies throughout our operation,” said Isom.

US Airways Group, Inc., through its subsidiaries, provides air transportation for passengers and cargo. It operates approximately 3,000 flights daily to 190 communities in the United States, Canada, Mexico, Europe, the Middle East, the Caribbean, and Central and South America.

http://www.usairways.com

__

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DoubleInStocks.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. (Read more at: http://doubleinstocks.com/disclaimer) Release of Liability: Through use of this website viewing or using, you agree to hold DoubleInStocks.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings, Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received five thousand dollars from a third party (VNC Associates LLC) for one (1) day of advertising for CANNABIS SCIENCE INC (OTC BB: CBIS.OB).

Sign Up for our FREE Daily Stock Newsletter

 

 

Tags:

alleviating nausea |  autoimmune diseases |  cannabis sativa |  Cannabis Science |  CANNABIS SCIENCE INC |  Epidemics |  legal use of marijuana |  medical marijuana |  neurological disorders |  otc:cbis |  phytocannabinoid |  phytocannabinoid science |  PINK:WPNV |  Robert Melamede |  Robert Petzel |  WindPower Innovations |  WPNV